World Molecular Imaging Congress

世界分子成像大会

• 批准号: 10753964
• 负责人: Vladimir Ponomarev
• 金额: $ 1万
• 依托单位: WORLD MOLECULAR IMAGING SOCIETY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-01 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10753964
• 关键词: Academia; Achievement; Area; Basic Science; Biological Process; Biology; Biomedical Engineering; Cardiology; Cardiovascular system; Categories; Chemistry; Clinic; Clinical Research; Collaborations; Communicable Diseases; Communities; Congresses; Coupled; Czech Republic; Data Science; Dedications; Detection; Development; Disabled Persons; Discipline; Disease; Early Diagnosis; Education; Educational workshop; Endocrinology; Engineering; Ensure; Equity; Event; Fostering; Funding; Future; Goals; Government; Growth; Healthcare; Hearing; Human Biology; Image; Imaging technology; Immunology; Immunotherapy; Industry; Infection; Inflammation; Interest Group; International; Leadership; Learning; Life; Lung; Medical; Medical Research; Medicine; Mind; Mission; Modality; Molecular; Molecular Biology; Nanotechnology; Narration; Nature; Neurology; Neurosciences; Oncology; Operative Surgical Procedures; Optics; Outcome; Pathogenesis; Patient Care; Patient-Focused Outcomes; Physicians; Physics; Postdoctoral Fellow; Research; Research Personnel; Rheumatology; Role; Science; Scientist; Secure; Societies; Students; Technology; Training; Translational Research; Travel; Trustees; Underrepresented Minority; Underrepresented Populations; Woman; Work; cancer prevention; career development; clinical care; clinical imaging; clinical translation; cost; doctoral student; graduate student; human disease; image guided therapy; improved; in vivo imaging; innovation; insight; instrumentation; meetings; member; molecular imaging; multidisciplinary; multimodality; next generation; novel strategies; preclinical imaging; prevent; programs; symposium; theranostics; tool; translational scientist; tumor heterogeneity; working group

World Molecular Imaging Congress 2023 Abstract Molecular imaging (MI) technologies are being used in multiple disciplines to transform our understanding of biology and pathogenesis, to drive detection to earlier and earlier stages of disease and refine therapies for nearly all human diseases. The field of MI represents a fusion of diverse scientific fields, including instrumentation physics, molecular biology, medicine, engineering and chemistry, and has a major impact on all areas of biomedicine. The World Molecular Imaging Society (WMIS) embodies the field of MI as an organization dedicated to developing and promoting preclinical and clinical imaging using all modalities that have the capability of providing cellular and molecular information in living subjects. The tools and technologies supported by the WMIS, and featured at its annual meeting called the World Molecular Imaging Congress (WMIC), are changing the fields of oncology, infectious disease, neurology, cardiology, rheumatology, and endocrinology. A distinguishing feature of the WMIS is the highly-integrated, multimodal nature of its program that begins with scientific innovation and extends to patient care. As an international scientific educational organization, active members of WMIS include basic and translational scientists, clinicians, young researchers and students from a wide variety of disciplines, with a common goal of understanding human biology and the critical cellular and molecular components of disease through in vivo imaging with quantitative multimodality MI. As an annual event, the WMIC is the only comprehensive, international meeting in the field of MI. The WMIC provides a platform for a wide array of scientists and clinicians with diverse areas of expertise to interact, present, and discuss cutting- edge advances in MI, and as such the meeting attracts scientists from academia, industry, and government. The main goal of the WMIC 2023 is to explore the expanding role of Molecular Imaging and its impact on advancing in healthcare. We will accomplish this by the following aims of this proposal: 1) presenting the latest advances and applications of MI; 2) improving the understanding of biological processes and using the gained insights to develop tools that help us to better prevent, detect and treat disease; and 3) Bring together an international community to promote and expand the use of MI to build a thriving scientific community that fosters innovation through the creation of an equitable, diverse, and inclusive workforce. We work diligently to secure travel funds for promising young scientists, post-doctoral and graduate students, to attend the meeting and to bring their innovative studies to the meeting and are committed to supporting young investigators, as they drive innovation in the field and apply MI in the clinic. The funds from this R13 will cover costs to support travel and attendance for the most promising young investigators, at the graduate and postdoctoral levels, especially encouraging women, underrepresented minorities and persons with disabilities, enabling them to attend the WMIC in Prague, Czech Republic on September 5 – 9, 2023.

2023年世界分子影像大会 摘要 分子成像（MI）技术正在多个学科中使用，以改变我们对 生物学和发病机制，以推动检测到疾病的早期和早期阶段，并完善治疗， 几乎所有的人类疾病。MI领域代表了不同科学领域的融合，包括仪器仪表 物理学、分子生物学、医学、工程学和化学，并对所有领域产生重大影响。 生物医药世界分子影像学会（WMIS）是MI领域的一个组织 致力于开发和推广临床前和临床成像，使用所有具有 提供活体细胞和分子信息的能力。支持的工具和技术 由WMIS，并在其年度会议上称为世界分子成像大会（WMIC），是 改变肿瘤学、传染病学、神经病学、心脏病学、风湿病学和内分泌学领域。一 WMIS的显著特点是其项目的高度集成性和多模式性， 科学创新，并延伸到病人护理。作为一个国际性的科学教育组织， WMIS的成员包括基础和转化科学家，临床医生，年轻的研究人员和学生， 广泛的学科，以了解人类生物学和关键的细胞和 通过定量多模态MI的体内成像来确定疾病的分子组成。作为一项年度活动， WMIC是MI领域唯一的综合性国际会议。WMIC提供了一个平台， 拥有不同专业领域的科学家和临床医生进行互动、展示和讨论切割- 该会议吸引了来自学术界、工业界和政府的科学家。的 WMIC 2023的主要目标是探索分子成像的扩展作用及其对推进 在医疗保健方面。我们将通过以下目标来实现这一目标：1）介绍最新进展 2）提高对生物过程的理解，并利用所获得的见解， 开发工具，帮助我们更好地预防、检测和治疗疾病;以及3）汇集一个国际性的 社区，以促进和扩大MI的使用，以建立一个繁荣的科学社区，促进创新 通过建立公平、多样化和包容性的劳动力队伍。我们努力工作，以确保旅行资金 有前途的青年科学家，博士后和研究生，参加会议，并带来他们的 创新研究的会议，并致力于支持年轻的研究人员，因为他们推动创新 并将MI应用于临床。R13的资金将用于支付差旅和出席会议的费用 对于最有前途的年轻研究人员，在研究生和博士后水平，特别令人鼓舞 妇女、代表性不足的少数民族和残疾人，使他们能够参加在布拉格举行的世界穆斯林大会， 捷克共和国，2023年9月5日至9日。